Search

everythinglearnresearchcommunity

for

Search:↓

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

The study developed a 3D model that closely imitates remaining ovarian cancer after treatment and identified a potential drug targeting resistant cancer cells.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

PCOS may increase the risk of certain cancers.

Wnt7a protein is crucial for development and tissue maintenance and plays varying roles in diseases and potential treatments.

Oral contraceptives provide various health benefits beyond birth control, including managing menstrual issues, skin conditions, pain, and reducing the risk of certain cancers.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Different types of fibroblasts play various roles in kidney repair and aging, and may affect chronic kidney disease outcomes.

FOXC1 boosts SFRP1 in hair loss, suggesting new treatments.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

A protein called sFRP4 can slow down hair regrowth.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

Albumin and prednisone improved symptoms in a woman with Cronkhite-Canada syndrome, revealing potential genetic causes.

Deleting the EDAR gene in Cashmere goats affects genes and proteins related to hair growth.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

A pregnant woman's skin condition improved after giving birth, possibly due to high estrogen levels during pregnancy.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.